← All indications
Hepatitis
INFLAMMATION of the LIVER.
Subtype terms (4)
More specific conditions that are subtypes of Hepatitis in the MeSH hierarchy.
- Hepatitis, Alcoholic
48 drugs (27 approved, 21 experimental)
- Hepatitis, Animal
- Hepatitis, Chronic
22 drugs (13 approved, 9 experimental)
- Hepatitis, Viral, Human
10 drugs (5 approved, 5 experimental)
Drugs by status
Approved for this indication (3)
Phase 4 trials (16)
Phase 3 trials (3)
Phase 2 trials (17)
Phase 1 trials (6)
Organizations
Organization Involved with Phase 4 Indications (421)
- Cornell University
- University of Sao Paulo
- National Cheng Kung University
- Isfahan University
- Gottfried Wilhelm Leibniz Universität Hannover
- University of London
- Community Research Initiative of New England
- Services Hospital, Lahore
- Menoufia University
- Chungbuk National University
- Chung-Ang University
- Southeast University
- United States Army
- State University of New York
- Hamadan University of Medical Science
- National Cancer Institute (NCI)
- State University of New York, Syracuse
- Huizhou People's Central Hospital
- SC Liver Research Consortium, LLC
- Gilead Sciences
- Norte Study Group
- Chacha Nehru Bal Chikitsalaya, New Delhi
- TEMPUS
- Rwanda Biomedical Center
- Rwanda Military Hospital
- Foo Yin Hospital
- Viet Tiep General Hospital
- Partners in Health
- The Fifth Hospital of Shijiazhuang
- Instituto de Estudios de Ciencias de la Salud de Castilla y León (IECSCYL)
- +391 more
Organization Involved with Phase 3 Indications (164)
- Fundación Pública Andaluza
- Suyash Hospital Pvt. Ltd
- Nanjing Sanhome Pharmaceutical, Co., Ltd.
- Tibotec
- Integrated Therapeutics Group
- Advanced Medical Services GmbH
- Government of Vietnam
- bny swif university
- Institute Of Cardiology & Internal Diseases, Kazakhstan
- Southern California Institute for Research and Education
- Eisai
- Medical Research Council, South Africa
- Government of Laos
- University of Alberta
- Jiangsu Hansoh Pharmaceutical Co., Ltd.
- Pars No Tarkib Co
- Kirov Military Medical Academy
- NUCLIMED
- Government of Indonesia
- University of Rennes
- Azienda Ospedaliera S Giovanni Battista
- University of Paris
- Sanjay Gandhi Postgraduate Institute of Medical Sciences
- University of Geneva
- Ghazza University
- University of Cape Town
- Diponegoro University
- Aalborg University
- King Fahad Medical City
- University of Massachusetts
- +134 more
Organization Involved with Phase 2 Indications (212)
- Triangle Pharmaceuticals
- Anza Therapeutics, Inc.
- PPD
- AIDS Clinical Trials Group
- Moscow Regional Resarch adn Clinical Institute
- Tacere Therapeutics, Inc.
- Vaxine Pty Ltd
- University of Pisa
- Thrasher Research Fund
- University of Oklahoma
- Chao Family Comprehensive Cancer Center
- Huntington Medical Research Institutes
- Badalona Hospital Germans Trias i Pujol
- Assembly Biosciences
- PharmaKing
- Cubist
- InSpira Medical
- Afimmune
- Immune Tolerance Network
- ChronTech Pharma AB
- CureTech Ltd
- Shanghai Sundise Traditional Chinese Medicine Co., Ltd.
- Hannover Medical School
- TaiGen Biotechnology Co., Ltd.
- All India Institute of Medical Sciences
- BioIncept LLC
- Can-Fite BioPharma
- Veloxis Pharmaceuticals
- Croix-Rousse Hospital, Lyon
- St. Luke's-Roosevelt Hospital Center
- +182 more
Organization Involved with Phase 1 Indications (59)
- Transition Therapeutics
- Changchun Institute of Biological Products Co., Ltd.
- University Health Network, Toronto
- Aceragen, Inc/
- Tower Cancer Research Foundation
- Spaulding Clinical Research Inc.
- Bach & Godofsky, MD, PA
- Hepion Pharmaceuticals
- Genexine, Inc.
- Microbio Co Ltd
- Nucorion Pharmaceuticals, Inc.
- Novira Therapeutics, Inc.
- Impact Clinical Trials
- City University of Hong Kong
- AIDS Research Consortium of Atlanta
- University of Edinburgh
- Cathay General Hospital
- Enanta Pharmaceuticals
- Maharaj Nakorn Chiang Mai Hospital
- Padjadjaran University
- Alamo Medical Research
- Temple University
- Orange Coast Medical Center
- Theravance
- Wyeth
- GeneOne Life Science
- Hengrui Therapeutics, Inc.
- INC Research
- Genentech
- Virobay Inc.
- +29 more
Organization Involved with Other Experimental Indications (51)
- Vietnamese Military
- Frontier Research Institute
- Universidad Autonoma del Estado de Mexico
- Hospital General Dr. Manuel Gea Gonzalez
- Ram Manohar Lohia Insitute of Medical Sciences
- Vietstar Biomedical Research
- Charles Drew University
- Hillel Yaffe Medical Center
- Indian Council of Medical Research
- Rockefeller University
- Saint Luke's Health System
- West Virginia University
- State Department of Health of Rio Grande do Sul
- Tran Minh Duc, Dr.
- Hangzhou Xixi hospital
- Eurasia Invest Ltd., Kazakhstan
- University of Kansas
- American College of Gastroenterology
- Asfendiyarov Kazakh National Medical University
- Medical University of Graz
- Hunan University of Traditional Chinese Medicine
- Mercy Hospital for Women, Australia
- Corporal Michael J. Crescenz VA Medical Center
- Triệu, Nguyễn Thị, M.D.
- Vabiotech
- Organic India
- Julius-Maximilians University
- Eastern Hepatobiliary Surgery Hospital
- Reliant Pharmaceuticals
- Sao Paulo State University
- +21 more